Key Statistics
EV/EBIT = 63.75x
ROE = 12.58%
Debt/Equity = 1%
FCF Yield = 3.15%
Dividend Yield = 0%
Market Cap = $32.88 billion
The Company
Veeva Systems (VEEV) is a leading cloud-based software company specializing in the life sciences industry.
The company was founded in 2007 by Peter Gassner and Matt Wallach. Initially, they focused on creating a customer relationship management (CRM) system specifically for life sciences, which they launched in 2010.
This product quickly gained popularity. Building on this success, Veeva introduced the Veeva Vault platform in 2012 and went public with an IPO in 2013.
Their innovative software solutions tackle the unique challenges of pharmaceutical, biotechnology, medical device, and consumer product companies. Veeva's primary mission is to empower these organizations to develop and market life-saving products efficiently while ensuring compliance with stringent regulatory requirements.
Veeva tailors its cloud platforms to meet the specific needs of the life sciences sector, where adherence to strict regulations and robust, secure data management is critical. These platforms provide efficient data storage and high-level security, which are essential for maintaining regulatory compliance and enhancing operational efficiency.
Traditionally, life sciences data was scattered across various systems, creating inefficiencies and hindering collaboration. Veeva's cloud solutions effectively address these issues by centralizing and streamlining data management, facilitating better collaboration and more efficient workflows.
At the heart of Veeva's offerings lies Veeva Vault, a secure and centralized cloud platform. This platform allows companies to organize and manage critical documents and information related to drug development, clinical trials, and marketing activities. By eliminating the inefficiencies of scattered data, Veeva Vault streamlines processes and significantly reduces drug development and marketing costs.
Regulatory compliance is an ever-present concern in the life sciences industry. Failure to adhere to these regulations can lead to delays in drug approvals and even legal issues. Veeva's suite of tools empowers companies to navigate this complex regulatory environment confidently. These tools provide functionalities like document management, regulatory submission support, and change control, ensuring companies stay compliant throughout the product lifecycle.
Veeva offers a comprehensive suite of cloud-based solutions categorized into three major product categories: